Mechanisms of Open and Hidden Placebo in Stroke Recovery
Launched by SPAULDING REHABILITATION HOSPITAL · Apr 24, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Mechanisms of Open and Hidden Placebo in Stroke Recovery," is exploring how placebos (which are treatments without active ingredients) can affect recovery after a stroke. Researchers want to understand if there are specific brain responses to open placebos (where patients know they are getting a placebo) and hidden placebos (where they don’t know). The goal is to find ways to use these findings to improve rehabilitation therapies for people recovering from a stroke.
To participate in this study, you need to be an adult aged 18 or older who has hemiparesis (weakness on one side of the body) due to a stroke that happened at least six months ago. You should also have a specific level of motor function and not have severe depression or other health issues that could interfere with the study. If you join, you can expect to take part in assessments that will help researchers learn more about how placebos impact recovery. Your participation could contribute to developing better treatments for stroke recovery in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adults with hemiparesis due to chronic stroke
- • 2. Stroke duration of 6 months or more
- • 3. Fugl-Meyer scale upper extremity motor assessment score of \> 11 and ≤ 56
- • 4. Pre-stroke disability (defined as a score of \< 3 on the Modified Rankin Scale)
- • 5. Age 18 or older
- Exclusion Criteria:
- • 1. Stroke of anterior cerebral artery territory with prefrontal lesion and stroke-related decreased EEG power in the prefrontal cortex
- • 2. Unable to understand instructions
- • 3. TMS contraindications: electronic hardware in close contact to the discharging coil such as cochlear implant, internal pulse generator or medical pump
- • 4. Concurrent unstable medical conditions
- • 5. A score of 24 or higher on the Hamilton Depression Rating Scale (HDRS)
- • 6. Joint or paretic extremity pain likely to interfere with assessments
- • 7. Pregnancy
About Spaulding Rehabilitation Hospital
Spaulding Rehabilitation Hospital is a leading academic medical center dedicated to advancing the field of rehabilitation medicine. Affiliated with Harvard Medical School, Spaulding is renowned for its commitment to patient-centered care, innovative research, and comprehensive rehabilitation services. The hospital actively conducts clinical trials to explore novel therapies and improve outcomes for individuals with disabilities and chronic conditions. Through collaboration with multidisciplinary teams and a focus on evidence-based practices, Spaulding Rehabilitation Hospital aims to enhance the quality of life for its patients while contributing to the advancement of rehabilitation science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cambridge, Massachusetts, United States
Patients applied
Trial Officials
Felipe Fregni, MD, PhD, MPH
Principal Investigator
Spaulding Rehabilitation Hospital/Harvard Medical School
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported